Logo
x

Search

Subscribe Now

Biocon Biologics

Biocon Biologics and Regeneron Settle over Yesafili’s (Biosimilar, Eylea) US Launch

Biocon Biologics and Regeneron Settle over Yesafili’s (Biosimilar, Eylea) US Launch

  • April 16, 2025
The US FDA Approves Biocon Biologics’ Jobevne (Biosimilar, Avastin)

The US FDA Approves Biocon Biologics’ Jobevne (Biosimilar, Avastin)

  • April 10, 2025
Biocon Biologics Partners with Civica to extend access of Insulin Aspart in the US

Biocon Biologics Partners with Civica to extend access of Insulin Aspart in the US

  • March 7, 2025
Biocon Biologics Report the P-III Study Positive Results of Yesintek (Biosimilar, Stelara)

Biocon Biologics Report the P-III Study Positive Results of Yesintek (Biosimilar, Stelara)

  • March 7, 2025
Biocon Biologics Launches Yesintek (Biosimilar, Stelara) in the US

Biocon Biologics Launches Yesintek (Biosimilar, Stelara) in the US

  • February 24, 2025
Biocon Biologics Reports the US FDA’s Approval of Yesintek (Biosimilar, Stelara)

Biocon Biologics Reports the US FDA’s Approval of Yesintek (Biosimilar, Stelara)

  • December 2, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.